Reply
- 作者David Welling; David G. Burris; John E. Hutton; Stanley L. Minken; Norman M. Rich
- 卷第204卷
- 期第1期
- 印刷ISSN1072-7515
- 文件大小54.15KB
- 发表时间2007
- DOI10.1016/j.jamcollsurg.2006.10.016
- 页码186-187
Therapy: microRNA suppresses liver cancerCrunkhorn, Sarah · 2009
Protein rescue to treat genetic disordersCrunkhorn, Sarah · 2007
An aid to digestionCrunkhorn, Sarah · 2007
Bypassing the side effects of thiazolidinediones?Crunkhorn, Sarah · 2007
A shared targetCrunkhorn, Sarah · 2007
Antimicrobials: Fighting resistanceCrunkhorn, Sarah · 2007
Anticancer drugs: Forecasting drug responsesCrunkhorn, Sarah · 2007
Inflammatory disorders: Chronically amplifying diseaseCrunkhorn, Sarah · 2007
Better antibiotics through chemistryFrantz, Simon · Nature Reviews Drug Discovery · 2004
Vioxx risk signifies trouble in classFrantz, Simon · Nature Reviews Drug Discovery · 2004
Inherent anticipationBecker, Daniel M. · Nature Reviews Drug Discovery · 2005
Merck and Integra battle onOwens, Joanna · Nature Reviews Drug Discovery · 2005
In BriefFrantz, Simon · Nature Reviews Drug Discovery · 2005
Can making a correlation be patented?Owens, Joanna · Nature Reviews Drug Discovery · 2005
Chronic myelogenous leukaemia marketStorey, Shane · Nature Reviews Drug Discovery · 2009
Neurodegenerative Disease: Rescuing memoryHarrison, Charlotte · Nature Reviews Drug Discovery · 2010